ARVN Arvinas, Inc.
$7.23▼ -1.09%
Healthcare
Other
Volume 55.2K
Avg Volume (10D) 706.2K
Key Metrics & Fundamentals
Market Cap
$466.49M
P/E Ratio
27.8
Div Yield
0.00%
52W Range
6.74 - 14.51
% vs 50 MA
-11.17%
% vs 200 MA
-25.22%
RSI-14
44.2
MACD Histogram
+0.0700
Beta (1Y vs SPY)
1.14
Free Cash Flow
-$48.50M
Gross Rev
$249.70M
Gross Profit
$249.70M
EBITDA
$165.30M
COGS
–
Operating Exp
$85.60M
Operating Income
$164.10M
EBIT
$164.10M
Pretax Income
$169.60M
Net Income
$169.40M
EPS (Diluted)
2.58
Price & Volume History
Loading chart…
Recent News
Arvinas to Report Third Quarter 2026 Financial Results on November 3, 2026
GlobeNewswire · Oct 27, 2026 7:00 AM ET
Could You Have Seen The Run In Kymera Stock Coming?
Trefis · Oct 26, 2026 5:34 PM ET
Can KYMR's Targeted Protein Degradation Pipeline Drive Future Growth?
Zacks · Oct 19, 2026 9:08 AM ET
Roche Gets FDA Approval for Enspryng in Thyroid Eye Disease
Zacks · Oct 16, 2026 10:21 AM ET
KRYS Reports Positive Early Data for KB113 in Gorlin Syndrome
Zacks · Oct 16, 2026 10:19 AM ET
Big Pharma Is Pouring Billions Into a New Class of ‘Protein Degrader’ Drugs
The Wall Street Journal · Oct 15, 2026 5:30 AM ET
Reasons Why Investors Should Consider Betting on Arvinas Stock
Zacks · Oct 13, 2026 10:27 AM ET
TGTX Stock Rises 60% in 6 Months: Here's What You Should Know
Zacks · Oct 13, 2026 9:47 AM ET
Mirum's Livmarli Meets Phase III Goal in Ultra-Rare Liver Diseases
Zacks · Oct 13, 2026 9:41 AM ET
Arvinas Shares Novel Oculomotor and Biomarker Data from Phase 1 Clinical Trial of ARV-102 in Patients with Parkinson’s Disease
GlobeNewswire · Oct 7, 2026 7:00 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See ARVN's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.